| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||
REGULAR ARTICLES
DR Senger
| You have reached the most complete version of this article accessible. |
This article has been cited by other articles:
![]() |
S.-C. Shih, A. Zukauskas, D. Li, G. Liu, L.-H. Ang, J. A. Nagy, L. F. Brown, and H. F. Dvorak The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis Cancer Res., April 15, 2009; 69(8): 3272 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Bachman, J. M. Phillips, and J. I. Goodman Phenobarbital Induces Progressive Patterns of GC-Rich and Gene-Specific Altered DNA Methylation in the Liver of Tumor-Prone B6C3F1 Mice Toxicol. Sci., June 1, 2006; 91(2): 393 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Davis and D. R. Senger Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization Circ. Res., November 25, 2005; 97(11): 1093 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Rugo, R. S. Herbst, G. Liu, J. W. Park, M. S. Kies, H. M. Steinfeldt, Y. K. Pithavala, S. D. Reich, J. L. Freddo, and G. Wilding Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results J. Clin. Oncol., August 20, 2005; 23(24): 5474 - 5483. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Saunders, K. J. Bayless, and G. E. Davis MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices J. Cell Sci., May 15, 2005; 118(10): 2325 - 2340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bayless and G. E. Davis Microtubule Depolymerization Rapidly Collapses Capillary Tube Networks in Vitro and Angiogenic Vessels in Vivo through the Small GTPase Rho J. Biol. Chem., March 19, 2004; 279(12): 11686 - 11695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H Wu, M. Guo, S. Y Yuan, and H. J Granger Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor J. Physiol., November 1, 2003; 552(3): 691 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hiran, J. E. Mazurkiewicz, P. Kreienberg, F. L. Rice, and S. E. LaFlamme Endothelial expression of the {alpha}6{beta}4 integrin is negatively regulated during angiogenesis J. Cell Sci., September 15, 2003; 116(18): 3771 - 3781. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bayless and G. E. Davis The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices J. Cell Sci., March 15, 2002; 115(6): 1123 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Bell, A. Mavila, R. Salazar, K. J. Bayless, S. Kanagala, S. A. Maxwell, and G. E. Davis Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling J. Cell Sci., January 8, 2001; 114(15): 2755 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davis, K. Pintar Allen, R Salazar, and S. Maxwell Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices J. Cell Sci., January 3, 2001; 114(5): 917 - 930. [Abstract] [PDF] |
||||
![]() |
D. R. Senger and L. Van De Water VEGF Expression by Epithelial and Stromal Cell Compartments : Resolving a Controversy Am. J. Pathol., July 1, 2000; 157(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
A. E. Mautes, M. R Weinzierl, F. Donovan, and L. J Noble Vascular Events After Spinal Cord Injury: Contribution to Secondary Pathogenesis Physical Therapy, July 1, 2000; 80(7): 673 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Davis, K. J. Bayless, M. J. Davis, and G. A. Meininger Regulation of Tissue Injury Responses by the Exposure of Matricryptic Sites within Extracellular Matrix Molecules Am. J. Pathol., May 1, 2000; 156(5): 1489 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bayless, R. Salazar, and G. E. Davis RGD-Dependent Vacuolation and Lumen Formation Observed during Endothelial Cell Morphogenesis in Three-Dimensional Fibrin Matrices Involves the {alpha}v{beta}3 and {alpha}5{beta}1 Integrins Am. J. Pathol., May 1, 2000; 156(5): 1673 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Padro, S. Ruiz, R. Bieker, H. Burger, M. Steins, J. Kienast, T. Buchner, W. E. Berdel, and R. M. Mesters Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia Blood, April 15, 2000; 95(8): 2637 - 2644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, K. Bell, S. A. Mousa, and J. A. Varner Regulation of Angiogenesis in Vivo by Ligation of Integrin {alpha}5{beta}1 with the Central Cell-Binding Domain of Fibronectin Am. J. Pathol., April 1, 2000; 156(4): 1345 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Brown, A. J. Guidi, S. J. Schnitt, L. Van De Water, M. L. Iruela-Arispe, T.-K. Yeo, K. Tognazzi, and H. F. Dvorak Vascular Stroma Formation in Carcinoma in Situ, Invasive Carcinoma, and Metastatic Carcinoma of the Breast Clin. Cancer Res., May 1, 1999; 5(5): 1041 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Armesilla, E. Lorenzo, P. Gomez del Arco, S. Martinez-Martinez, A. Alfranca, and J. M. Redondo Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression Mol. Cell. Biol., March 1, 1999; 19(3): 2032 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Senger, K. P. Claffey, J. E. Benes, C. A. Perruzzi, A. P. Sergiou, and M. Detmar Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha 1beta 1 and alpha 2beta 1 integrins PNAS, December 9, 1997; 94(25): 13612 - 13617. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O SCHLINGEMANN and V. W M VAN HINSBERGH Role of vascular permeability factor/vascular endothelial growth factor in eye disease Br. J. Ophthalmol., June 1, 1997; 81(6): 501 - 512. [Full Text] [PDF] |
||||
![]() |
F. Yuan, Y. Chen, M. Dellian, N. Safabakhsh, N. Ferrara, and R. K. Jain Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody PNAS, December 10, 1996; 93(25): 14765 - 14770. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||